Edgar Filing: KIMBERLY CLARK CORP

kc_10q-1q09.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

(Mark One)

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2009

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from.............to.....................

Commission file number 1-225

KIMBERLY-CLARK CORPORATION

(Exact name of registrant as specified in its charter)

Delaware	39-0394230
(State or other jurisdiction of	(I.R.S. Employer
incorporation or organization)	Identification No.)

P. O. Box 619100

Dallas, Texas

75261-9100

(Address of principal executive offices)

(Zip Code)

(972) 281-1200

(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes x No ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulations S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).

Yes ¨ No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer x	Accelerated filer ¨
Non-accelerated filer ¨ (Do not check if a smaller reporting company)	Smaller reporting company ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes ¨ No x

As of April 30, 2009, there were 414,205,922 shares of the Corporation’s common stock outstanding.

PART I – FINANCIAL INFORMATION

Item 1. Financial Statements.

KIMBERLY-CLARK CORPORATION AND SUBSIDIARIES

CONSOLIDATED INCOME STATEMENT

(Unaudited)

	Three Months Ended
	March 31
(Millions of dollars, except per share amounts)	2009			2008

Net Sales	$	4,493		$	4,813
Cost of products sold		3,039			3,357

Gross Profit		1,454			1,456
Marketing, research and general expenses		749			799
Other (income) and expense, net		77			(7	)

Operating Profit		628			664
Interest income		8			8
Interest expense		(73	)		(74	)

Income Before Income Taxes and
Equity Interests		563			598
Provision for income taxes		(164	)		(165	)

Income Before Equity Interests		399			433
Share of net income of equity companies		32			43

Net Income		431			476
Net income attributable to noncontrolling interests		(24	)		(35	)

Net Income Attributable to Kimberly-Clark Corporation	$	407		$	441

Per Share Basis:

Net Income Attributable to Kimberly-Clark Corporation
Basic	$	.98		$	1.05

Diluted	$	.98		$	1.04

Cash Dividends Declared	$	.60		$	.58

See Notes to Consolidated Financial Statements.

KIMBERLY-CLARK CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEET

(Unaudited)

	March 31,		December 31,
(Millions of dollars)	2009		2008

ASSETS

Current Assets
Cash and cash equivalents	$	592	$	364
Accounts receivable, net		2,385		2,492
Inventories		2,187		2,493
Other current assets		341		464
Total Current Assets		5,505		5,813

Property		15,563		15,723
Less accumulated depreciation		8,081		8,056
Net Property		7,482		7,667

Investments in Equity Companies		350		324

Goodwill		2,712		2,743

Long-Term Notes Receivable		604		603

Other Assets		920		939
	$	17,573	$	18,089

LIABILITIES AND STOCKHOLDERS’ EQUITY

Current Liabilities
Debt payable within one year	$	1,314	$	1,083
Accounts payable		1,427		1,603
Accrued expenses		1,520		1,723
Other current liabilities		519		343
Total Current Liabilities		4,780		4,752

Long-Term Debt		4,875		4,882
Noncurrent Employee Benefits		2,519		2,593
Long-Term Income Taxes Payable		145		189
Deferred Income Taxes		200		193
Other Liabilities		195		187
Redeemable Preferred and Common Securities of Subsidiaries		1,046		1,032

Stockholders’ Equity
Kimberly-Clark Corporation		3,575		3,878
Noncontrolling Interests		238		383
Total Stockholders’ Equity		3,813		4,261

	$	17,573	$	18,089

See Notes to Consolidated Financial Statements.

KIMBERLY-CLARK CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED CASH FLOW STATEMENT

(Unaudited)

	Three Months
	Ended March 31
(Millions of dollars)	2009			2008

Operating Activities
Net income	$	431		$	476
Depreciation and amortization		177			200
Stock-based compensation		10			18
Decrease (increase) in operating working capital		156			(231	)
Deferred income taxes		(46	)		8
Net losses on asset dispositions		8			10
Equity companies’ earnings in excess of dividends paid		(32	)		(43	)
Postretirement benefits		(21	)		(8	)
Other		9			14

Cash Provided by Operations		692			444

Investing Activities
Capital spending		(211	)		(221	)
Acquisition of businesses, net of cash acquired		(11	)		(17	)
Proceeds from sales of investments		5			23
Proceeds from dispositions of property		3			-
Net decrease in time deposits		57			47
Other		(12	)		(2	)

Cash Used for Investing		(169	)		(170	)

Financing Activities
Cash dividends paid		(240	)		(224	)
Net increase in short-term debt		245			168
Proceeds from issuance of long-term debt		2			31
Repayments of long-term debt		(10	)		(4	)
Cash paid on redeemable preferred securities of subsidiary		(13	)		(7	)
Shares purchased from noncontrolling interests		(278	)		-
Proceeds from exercise of stock options		16			54
Acquisitions of common stock for the treasury		-			(208	)
Other		(17	)		(29	)

Cash Used for Financing		(295	)		(219	)

Effect of Exchange Rate Changes on Cash and Cash Equivalents		-			(3	)
Increase in Cash and Cash Equivalents		228			52
Cash and Cash Equivalents, beginning of year		364			473

Cash and Cash Equivalents, end of period	$	592		$	525

See Notes to Consolidated Financial Statements.

KIMBERLY-CLARK CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME

(Unaudited)

	Three Months Ended March 31
(Millions of dollars)	2009			2008

Net Income	$	431		$	476

Other Comprehensive Income, Net of Tax:
Unrealized currency translation adjustments		(361	)		291
Employee postretirement benefits		32			(6	)
Other		(6	)		(22	)
Total Other Comprehensive Income, Net of Tax		(335	)		263

Comprehensive Income		96			739

Comprehensive income attributable to noncontrolling interests		(9	)		21

Comprehensive Income Attributable to Kimberly-Clark Corporation	$	105		$	718

See Notes to Consolidated Financial Statements.

KIMBERLY-CLARK CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

Note 1. Accounting Policies

Basis of Presentation

The accompanying unaudited condensed Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S.”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the U.S. for complete financial statements. In the opinion of management, all adjustments, consisting of normal recurring adjustments, considered necessary for a fair presentation have been included.

For further information, refer to the Consolidated Financial Statements and footnotes thereto included in the Corporation’s Annual Report on Form 10-K for the year ended December 31, 2008.

New Accounting Standards

Effective January 1, 2009, the Corporation adopted Statement of Financial Accounting Standards (“SFAS”) No. 141(R), Business Combinations, and FASB Staff Position (“FSP”) No. FAS 141(R)-1, Accounting for Assets Acquired and Liabilities Assumed in a Business Combination That Arise from Contingencies, as required. These standards require the acquirer in a business combination to:

recognize 100 percent of the fair values of acquired assets, including goodwill, and assumed liabilities, with only limited exceptions, even if the acquirer has not acquired 100 percent of the target entity,

expense transaction costs as incurred rather than include as part of the fair value of an acquirer’s interest,

fair value contingent consideration arrangements at the acquisition date,

fair value certain pre-acquisition contingencies,

limit accrual of the costs for a restructuring plan to pre-acquisition date restructuring obligations, and

capitalize the value of acquired research and development as an indefinite-lived intangible asset, subject to impairment accounting, rather than being expensed at the acquisition date.

Adoption of these standards did not have a material effect on the Corporation's financial statements.

Effective January 1, 2009, the Corporation adopted SFAS No. 160, Noncontrolling Interests in Consolidated Financial Statements, an amendment of ARB No. 51 (“SFAS 160”), as required. See Note 7 for additional detail.

Note 1. (Continued)

Effective January 1, 2009, the Corporation adopted SFAS No. 161, Disclosures about Derivative Instruments and Hedging Activities, an amendment of FASB Statement No. 133, as required. See Note 8.

Effective January 1, 2009, the Corporation adopted FSP No. EITF 03-6-1, Determining Whether Instruments Granted in Share-Based Payment Transactions Are Participating Securities, as required. The FSP specifies that certain share-based payment awards that are entitled to nonforfeitable dividends or dividend equivalents are participating securities, which must be included in the computation of basic and diluted earnings per share under the two-class method prescribed in SFAS No. 128, Earnings per Share. Under the two-class method, earnings per share is computed by allocating net income between common stockholders and participating securities.

In accordance with the FSP, the Corporation’s basic and diluted earnings per share amounts have been recast from amounts previously reported as follows:

	As Previously Reported				As Recast
	Basic		Diluted		Basic		Diluted

2008:
First Quarter	$	1.05	$	1.04	$	1.05	$	1.04
Second Quarter		1.00		0.99		0.99		0.99
Third Quarter		1.00		0.99		0.99		0.99
Fourth Quarter		1.01		1.01		1.01		1.01
Full Year		4.06		4.04		4.04		4.03

2007		4.13		4.09		4.11		4.08

2006		3.27		3.25		3.26		3.24

2005		3.30		3.28		3.30		3.28

In April 2009, the FASB issued FSP No. FAS 107-1 and APB 28-1, Interim Disclosures about Fair Value of Financial Instruments. This FSP requires disclosures about the fair value of financial instruments in quarterly financial statements as well as in annual financial statements. This FSP is effective for interim reporting periods ending after June 15, 2009. Since the FSP only requires additional disclosures, it will not have a financial impact on the Corporation’s financial statements.

In April 2009, the FASB issued FSP No. FAS 115-2 and FAS 124-2, Recognition and Presentation of Other-Than-Temporary Impairments. This FSP amends the other-than-temporary impairment guidance for debt securities to make it more operational and to improve the presentation and disclosure of other-than-temporary impairments of debt and equity securities in the financial statements. This FSP is effective for interim and annual reporting periods ending after June 15, 2009. Adoption of the FSP is not expected to have a material effect on the Corporation’s financial statements.

In April 2009, the FASB issued FSP No. FAS 157-4, Determining Fair Value When the Volume and Level of Activity for the Asset or Liability Have Significantly Decreased and Identifying Transactions That Are Not Orderly. This FSP provides guidance for estimating fair values when there is no active market or where the price inputs being used represent distressed sales and identifying circumstances that indicate a transaction is not orderly. This FSP is effective for interim and annual reporting periods ending after June 15, 2009. Adoption of the FSP is not expected to have a material effect on the Corporation’s financial statements.

Note 2. Fair Value Measurements

As required, the Corporation has adopted SFAS No. 157, Fair Value Measurements (“SFAS 157”). SFAS 157 establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The three levels in the hierarchy used to measure fair value are:

Level 1 – Unadjusted quoted prices in active markets accessible at the reporting date for identical assets and liabilities.

Level 2 – Quoted prices for similar assets or liabilities in active markets. Quoted prices for identical or similar assets and liabilities in markets that are not considered active or financial instruments for which all significant inputs are observable, either directly or indirectly.

Level 3 – Prices or valuations that require inputs that are significant to the valuation and are unobservable.

A financial instrument’s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement.

Set forth below are the assets and liabilities that are measured on a recurring basis at fair value as of March 31, 2009, together with the inputs used to develop those fair value measurements. The Corporation has no assets or liabilities for which fair value was measured on a recurring basis using Level 3 inputs.

		Fair Value Measurements
(Millions of dollars)	March 31, 2009	Level 1	Level 2

Assets
Company-owned life insurance (“COLI”)	$ 37	$ -	$ 37
Available-for-sale securities	10	10	-
Derivatives	65	-	65

Total	$ 112	$ 10	$ 102

Liabilities
Derivatives	$ 72	$ -	$ 72

The COLI policies are a source of funding primarily for the Corporation’s nonqualified employee benefits and are included in other assets. Available-for-sale securities are included in other assets. The derivative assets and liabilities are included in other current assets, other assets, accrued expenses and other liabilities, as appropriate.

Level 1 Fair Values - The fair values of available-for-sale securities are based on quoted market prices in active markets for identical assets.

Note 2. (Continued)

Level 2 Fair Values - The fair value of the COLI policies is derived from investments in a mix of money market, fixed income and equity funds managed by unrelated fund managers. The fair values of derivatives used to manage interest rate risk and commodity price risk are based on LIBOR rates and interest rate swap curves and NYMEX price quotations, respectively. The fair value of hedging instruments used to manage foreign currency risk is based on quotations of spot currency rates and forward points, which are converted into implied forward currency rates.

Note 3. Strategic Cost Reduction Plan

In July 2005, the Corporation authorized a multi-year plan to further improve its competitive position by accelerating investments in targeted growth opportunities and strategic cost reductions aimed at streamlining manufacturing and administrative operations, primarily in North America and Europe. The strategic cost reductions commenced in the third quarter of 2005 and were completed by December 31, 2008. As of that date, $16 million of accrued expenses were recorded on the Corporation’s balance sheet. During the first quarter of 2009, cash payments of $8 million and $1 million of foreign currency adjustments reduced the accrual to approximately $7 million at March 31, 2009. Approximately $2 million will be paid in the second quarter of 2009 and the balance will be paid when the liabilities mature.

Note 4. Inventories

The following schedule presents inventories by major class:


	March 31, 2009								December 31, 2008
Summary of Inventories	LIFO			Non- LIFO		Total			LIFO			Non- LIFO		Total

At the lower of cost determined on the
FIFO or weighted-average cost methods
or market:
Raw materials	$	133		$	288	$	421		$	150		$	367	$	517
Work in process		199			124		323			246			133		379
Finished goods		615			771		1,386			758			832		1,590
Supplies and other		-			261		261			-			262		262
		947			1,444		2,391			1,154			1,594		2,748

Excess of FIFO or weighted-average
cost over LIFO cost		(204	)		-		(204	)		(255	)		-		(255	)

Total	$	743		$	1,444	$	2,187		$	899		$	1,594	$	2,493

The Corporation uses the LIFO method of valuing inventory for financial reporting purposes for most U.S. inventories. An actual valuation of inventory under the LIFO method is made at the end of each year based on the inventory levels and costs at that time. Accordingly, interim LIFO calculations are based on management’s estimates of expected year-end inventory levels and costs and are subject to the final year-end LIFO inventory valuation.

Note 5. Employee Postretirement Benefits

The table below presents the interim period disclosures required by SFAS No. 132 (revised 2003), Employers’ Disclosures about Pensions and Other Postretirement Benefits:

	Defined						Other Postretirement
	Benefit Plans						Benefit Plans
	Three Months Ended March 31
(Millions of dollars)	2009			2008			2009		2008

Service cost	$	16		$	20		$	3	$	3
Interest cost		77			82			13		13
Expected return on plan assets		(65	)		(94	)		-		-
Recognized net actuarial loss		43			14			-		1
Other		1			4			1		1
Net periodic benefit cost	$	72		$	26		$	17	$	18

During the first quarter of 2009 and 2008, the Corporation made cash contributions of approximately $90 million and $36 million, respectively, to its pension trusts. The Corporation currently anticipates contributing about $530 million for the full year 2009 to its pension trusts.

Note 6. Earnings Per Share

There are no adjustments required to be made to net income for purposes of computing basic and diluted EPS. The average number of common shares outstanding is reconciled to those used in the basic and diluted EPS computations as follows:

	Three Months
	Ended March 31
(Millions of shares)	2009	2008

Average shares outstanding	413.7	420.2
Participating securities	1.9	1.5
Basic	415.6	421.7
Dilutive effect of stock options	.1	1.7
Dilutive effect of restricted share and restricted
share unit awards	.2	.2
Diluted	415.9	423.6

Options outstanding during the three-month periods ended March 31, 2009 and 2008 to purchase 24.1 million and 7.8 million shares of common stock, respectively, were not included in the computation of diluted EPS because the exercise prices of the options were greater than the average market price of the common shares during the periods.

The number of common shares outstanding as of March 31, 2009 and 2008 was 413.9 million and 419.1 million, respectively.

Note 7. Stockholders’ Equity

Adoption of SFAS 160

SFAS 160 changes the classification of noncontrolling interests (formerly, minority owners’ interest in subsidiaries) in consolidated balance sheets and the accounting for and reporting of transactions between the reporting entity and holders of such noncontrolling interests. Under SFAS 160:

Noncontrolling interests are reported as an element of consolidated equity, thereby eliminating the prior practice of classifying minority owners’ interests within a mezzanine section of the balance sheet.

Reported net income includes the total income of all consolidated subsidiaries, with separate disclosure on the face of the income statement of the split of net income between the controlling and noncontrolling interests.

Increases and decreases in the noncontrolling ownership interest amount are accounted for as equity transactions. If the controlling interest loses control and deconsolidates a subsidiary, full gain or loss on the transition is recognized.

Adoption of SFAS 160 is prospective; however, prior year amounts in the consolidated financial statements have been recast to conform to the following requirements of SFAS 160:

Noncontrolling interests, which are not redeemable at the option of the noncontrolling interests, were reclassified from the mezzanine to equity, separate from the parent’s stockholders’ equity, in the consolidated balance sheet. Common securities, redeemable at the option of the noncontrolling interest, carried at redemption value of approximately $35 million are classified in a line item combined with redeemable preferred securities of subsidiary in the consolidated balance sheet.

Consolidated net income was recast to include net income attributable to both controlling and noncontrolling interests.

Note 7. (Continued)

Set forth below is a reconciliation of comprehensive income and stockholders’ equity attributable to

Kimberly-Clark Corporation and noncontrolling interests. Also reconciled is the redeemable preferred and common securities of subsidiaries, which is required to be classified outside of stockholders’ equity.

				Stockholders’ Equity Attributable to
	Comprehensive Income			The Corporation			Noncontrolling Interests			Redeemable Securities of Subsidiaries
Balance at December 31, 2008				$	3,878		$	383		$	1,032

Purchase of subsidiary shares
from noncontrolling interests					(170	)		(108	)		-

Comprehensive Income:
Net income	$	431			407			10			14

Other Comprehensive income, net of tax:
Unrealized translation		(361	)		(330	)		(31	)		-
Employee postretirement benefits		32			34			(2	)		-
Other		(6	)		(6	)		-			-
Total Comprehensive Income	$	96

Stock-based awards and other					10			(1	)		13
Dividends declared					(248	)		(13	)		-
Return on redeemable preferred securities					-			-			(13	)

Balance at March 31, 2009				$	3,575		$	238		$	1,046

Net unrealized currency gains or losses resulting from the translation of assets and liabilities of non-U.S. subsidiaries, except those in highly inflationary economies, are accumulated in a separate section of stockholders’ equity. For these operations, changes in exchange rates generally do not affect cash flows; therefore, unrealized translation adjustments are recorded in stockholders’ equity rather than income. Upon sale or substantially complete liquidation of any of these subsidiaries, the applicable unrealized translation adjustment would be removed from stockholders’ equity and reported as part of the gain or loss on the sale or liquidation.

Also included are the effects of foreign exchange rate changes on intercompany balances of a long-term investment nature and transactions designated as hedges of net foreign investments.

The net unrealized currency translation adjustments for the three months ended March 31, 2009 are primarily due to a strengthening of the U.S. dollar versus the euro, South Korean won, Swiss franc and the Colombian peso.

Note 7. (Continued)

				Stockholders’ Equity Attributable to
	Comprehensive Income			The Corporation			Noncontrolling Interests			Redeemable Securities of Subsidiaries
Balance at December 31, 2007				$	5,224		$	463		$	1,026

Comprehensive Income:
Net income	$	476			441			21			14

Other Comprehensive income, net of tax:
Unrealized translation		291			300			(9	)		-
Employee postretirement benefits		(6	)		(1	)		(5	)		-
Other		(22	)		(22	)		-			-
Total Comprehensive Income	$	739

Stock-based awards and other					72			-			-
Shares repurchased					(202	)		-			-
Dividends declared					(244	)		(32	)		-
Return on redeemable preferred securities					-			-			(7	)

Balance at March 31, 2008				$	5,568		$	438		$	1,033

SFAS 160 requires that the purchase of additional ownership in an already controlled subsidiary be treated as an equity transaction with no gain or loss recognized in consolidated net income or comprehensive income. However, SFAS 160 also requires the presentation of the below schedule displaying the effect of a change in ownership interest between the Corporation and a noncontrolling interest.

	Three Months Ended March 31
(Millions of dollars)	2009			2008

Net Income attributable to Kimberly-Clark Corporation	$	407		$	441

Decrease in Kimberly-Clark Corporation’s additional paid-in capital for purchase of
remaining shares in its Andean subsidiary(a)		(133	)		-

Change from net income attributable to Kimberly-Clark Corporation and transfers
to noncontrolling interests	$	274		$	441

(a)

During the first quarter of 2009, the Corporation acquired the remaining approximate 31 percent interest in its Andean region subsidiary, Colombiana Kimberly Colpapel S.A., for $289 million. In accordance with SFAS 160, the acquisition was recorded as an equity transaction that reduced noncontrolling interests, accumulated other comprehensive income and additional paid-in capital classified in stockholders’ equity by approximately $278 million and increased investments in equity companies by approximately $11 million.

Note 8. Risk Management

As a multinational enterprise, the Corporation is exposed to risks, such as changes in foreign currency exchange rates, interest rates and commodity prices. The Corporation employs a variety of practices to manage these risks, including operating and financing activities and, where deemed appropriate, the use of derivative instruments. The Corporation’s policies allow the use of derivatives for risk management purposes and prohibit their use for speculation. The Corporation’s policies also prohibit the use of any leveraged derivative instrument. Foreign currency derivative instruments, interest rate swaps and natural gas hedging contracts are entered into with major financial institutions.

Foreign Currency Exchange Risk Management

The Corporation has a centralized U.S. dollar functional currency international treasury operation (“In-House Bank”) that manages foreign currency exchange risks by netting exposures on a daily basis of recorded assets and liabilities of its non-U.S. dollar exposures and entering into derivative instruments with third parties whenever the net exposure in any single currency exceeds predetermined limits. These derivative instruments are not designated as hedging instruments. Changes in the fair value of these instruments are recorded in earnings when they occur. The In-House Bank also records the gain or loss on the translation of its non-U.S. dollar denominated monetary assets and liabilities in earnings. Consequently, the effect on earnings from the use of these non-designated derivatives is substantially neutralized by the recorded transactional gains and losses. The In-House Bank’s daily notional derivative positions with third parties averaged approximately $1.4 billion in the first quarter of 2009 and its average net exposure for the quarter was $1.0 billion. The In-House Bank used eight counterparties for its foreign exchange forward contracts.

The Corporation enters into derivative instruments to hedge a portion of the foreign currency exposures of its non-U.S. operations principally for their forecasted purchases of pulp, which are priced in U.S. dollars. The derivative instruments used to manage these exposures are designated and qualify as cash flow hedges. The Corporation also hedges a portion of the foreign currency exposures of its non-U.S. operations for imported intercompany finished goods priced in U.S. dollars and euros through the use of derivative instruments that are designated and qualify as cash flow hedges. Gains and losses on these cash flow hedges, to the extent effective, are recorded in other comprehensive income net of related income taxes and released to earnings as the related finished goods inventory containing the pulp and imported intercompany finished goods are sold to unaffiliated customers. As of March 31, 2009, the Corporation had approximately $548 million of outstanding forward contracts designated as cash flow hedges for the forecasted purchases of pulp and forecasted purchases of intercompany finished goods.

In addition, as of March 31, 2009, the Corporation had outstanding forward contracts designated as fair value hedges with third parties for U.S. dollar denominated intercompany debt of certain non-U.S. affiliates aggregating to $121 million.

The foreign currency exposure on intercompany loans of a long-term investment nature is hedged with derivative instruments with third parties. These derivatives are not designated as hedging instruments. At March 31, 2009, the notional amount of such derivative positions was $314 million.

Note 8. (Continued)

Foreign Currency Translation Risk Management

Translation adjustments result from translating foreign entities’ financial statements to U.S. dollars from their functional currencies. Translation exposure generally is not hedged. However, consistent with prior years, a portion of the Corporation’s net investment in its Mexican affiliate has been hedged. At March 31, 2009, the Corporation had in place net investment hedges of approximately $90 million for a portion of its investment in its Mexican affiliate. There was no significant ineffectiveness on these hedges as of March 31, 2009.

Interest Rate Risk Management

Interest rate risk is managed using a portfolio of variable- and fixed-rate debt composed of short- and long-term instruments and interest rate swaps. The objective is to maintain a cost-effective mix that management deems appropriate. From time to time, the Corporation enters into interest rate swap contracts, which are derivative instruments, to facilitate the maintenance of the desired ratio of variable- and fixed-rate debt. These derivative instruments are designated and qualify as fair value hedges. At March 31, 2009, the Corporation had no interest rate swap contracts in place.

From time to time, the Corporation uses derivatives to hedge the anticipated issuance of fixed-rate debt. These exposures are hedged with forward-starting swaps or “treasury locks” (e.g., a 10-year “treasury lock” hedging the anticipated issuance of 10-year debt). At March 31, 2009, the Corporation had several outstanding treasury locks with an aggregate notional value of $250 million.

Commodity Price Risk Management

The Corporation uses derivative instruments to offset a portion of its exposure to market risk arising from changes in the price of natural gas. Hedging of this risk is accomplished by entering into forward swap contracts, which are designated as hedges of specific quantities of natural gas expected to be purchased in future months. The fair values of these readily marketable swap contracts are recorded in the Corporation’s Consolidated Balance Sheet as an asset or liability, as appropriate. On the date the derivative contract is entered into, the Corporation formally documents and designates the swap contract as a cash flow hedge, including designating how the effectiveness of the hedge will be measured. This process links the swap contract to specific forecasted transactions.

As of March 31, 2009, the Corporation had outstanding commodity forward contracts to hedge forecasted purchases of approximately 50 percent of the Corporation’s estimated natural gas requirements for the balance of the current year and a lesser percentage for future periods.

Effect of Derivative Instruments on Results of Operations and Other Comprehensive Income

Fair Value Hedges

Derivative instruments that are designated and qualify as fair value hedges are used by the Corporation to manage interest rate risk and certain U.S. dollar denominated intercompany debt of non-U.S. affiliates. The realized gain or loss on the derivatives that hedge interest rate risk is amortized to interest expense over the life of the related debt. The fair values of these instruments are recorded in the Corporation’s Consolidated Balance Sheet as an asset or liability, as appropriate, with the offset recorded in current earnings. The offset to the change in fair values of the hedged debt instruments also is recorded in current earnings. Changes in the fair value of derivative instruments that hedge the U.S. dollar denominated intercompany debt are recorded in current earnings as well as the change in fair value of the hedged intercompany debt.

Note 8. (Continued)

The Corporation’s fair value hedges resulted in no significant ineffectiveness in the three-month period ended March 31, 2009. For the three-month periods ended March 31, 2009 and 2008, no gain or loss was recognized in earnings as a result of a hedged firm commitment no longer qualifying as a fair value hedge.

Cash Flow Hedges

For derivative instruments that are designated and qualify as cash flow hedges (e.g., hedging a portion of the currency exposure on the forecasted U.S. dollar denominated purchases of pulp by the Corporation’s non-U.S. subsidiaries), the effective portion of the gain or loss on the derivative instrument is initially recorded in other comprehensive income and reclassified to income in the same period that the hedged exposure affects income. Changes in the fair values of derivative instruments used to hedge the price of natural gas, to the extent effective, are recorded in other comprehensive income, net of related income taxes, and recognized in income at the time the cost of the natural gas is recognized in income.

The Corporation’s cash flow hedges resulted in no significant ineffectiveness in the three-month period ended March 31, 2009. For the three-month periods ended March 31, 2009 and 2008, no gains or losses were reclassified into earnings as a result of the discontinuance of cash flow hedges due to the original forecasted transaction no longer being probable of occurring within the time frames specified in SFAS No. 133, Accounting for Derivative Instruments and Hedging Activities. At March 31, 2009, the Corporation expected to reclassify $11 million of after-tax losses from accumulated other comprehensive income primarily to cost of sales during the next twelve months, consistent with the timing of the underlying hedged transactions. The maximum maturity of cash flow hedges in place at March 31, 2009 is December 2011.

Credit-risk-related Contingent Features

Certain of the Corporation’s derivative agreements contain credit support provisions that require the Corporation to post collateral if certain value or ratings thresholds are exceeded. As of March 31, 2009, the Corporation had posted no collateral under these agreements, which have a contract value of approximately $7 million.

Quantitative Information about the Corporation’s use of Derivative Instruments

The following tables display the location and fair values of derivative instruments presented in the Corporation’s Consolidated Balance Sheet and the location and amount of gains and losses reported in the Corporation’s Consolidated Income Statement and Statement of Other Comprehensive Income (“OCI”).

The Effect of Derivative Instruments on the Consolidated Income Statement for the Periods Ended March 31, 2009 and 2008 – (Millions of dollars)
Foreign exchange contracts	Income Statement Classification	Gain or (Loss) Recognized in Income
		2009			2008
Fair Value Hedges	Other income and (expense), net	$	(15	)	$	1

Undesignated Hedging Instruments	Other income and (expense), net(a)	$	(76	)	$	28

Note 8. (Continued)

	Amount of Gain or (Loss) Recognized In OCI						Income Statement Classification of Gain or (Loss) Reclassified from OCI	Gain or (Loss) Reclassified from OCI into Income
	2009			2008				2009			2008
Cash Flow Hedges

Interest rate contracts	$	7		$	(9	)	Interest Expense	$	1		$	1
Foreign exchange contracts		18			(22	)	Cost of Sales		18			(11	)
Commodity contract		(22	)		3		Cost of Sales		(12	)		(2	)

Total	$	3		$	(28	)		$	7		$	(12	)

Net Investment Hedges
Foreign exchange contracts	$	(8	)	$	(2	)		$	-		$	-

(a)

The vast majority of the gains and (losses) on these instruments arise from derivatives entered into with third parties by the In-House Bank. As previously noted, the In-House Bank also records gains and (losses) on the translation of its non-U.S. dollar denominated monetary assets and liabilities in earnings. Consequently, the effect on earnings from the use of these non-designated derivatives is substantially neutralized by the recorded transactional gains and losses.

Fair Values of Derivative Instruments
	Asset Derivatives
(Millions of dollars)	March 31, 2009			March 31, 2008
	Balance			Balance
	Sheet	Fair		Sheet	Fair
	Location	Value		Location	Value

Derivatives designated as hedging instruments:

Interest rate contracts	Other assets	$	10	Other assets	$	34
Foreign exchange contracts	Other current assets		25	Other current assets		4
Commodity contracts			-	Other current assets		3

Total		$	35		$	41

Undesignated Derivatives:

Foreign exchange contracts	Other current assets	$	30	Other current assets	$	18

Total asset derivatives		$	65		$	59

Fair Values of Derivative Instruments
	Liability Derivatives
(Millions of dollars)	March 31, 2009			March 31, 2008
	Balance			Balance
	Sheet	Fair		Sheet	Fair
	Location	Value		Location	Value

Derivatives designated as hedging instruments:

Interest rate contracts	Accrued expenses	$	5	Other liabilities	$	9
Foreign exchange contracts	Accrued expenses		13	Accrued expenses		27
Commodity contracts	Accrued expenses		26	Accrued expenses		2
Commodity contracts	Other liabilities		3			-

Total		$	47		$	38

Undesignated Derivatives:

Foreign exchange contracts	Accrued expenses	$	25	Accrued expenses	$	6

Total liability derivatives		$	72		$	44

Note 9. Description of Business Segments

The Corporation is organized into operating segments based on product groupings. These operating segments have been aggregated into four reportable global business segments: Personal Care; Consumer Tissue; K-C Professional & Other; and Health Care. The reportable segments were determined in accordance with how the Corporation’s executive managers develop and execute the Corporation’s global strategies to drive growth and profitability of the Corporation’s worldwide Personal Care, Consumer Tissue, K-C Professional & Other and Health Care operations. These strategies include global plans for branding and product positioning, technology, research and development programs, cost reductions including supply chain management, and capacity and capital investments for each of these businesses. Segment management is evaluated on several factors, including operating profit. Segment operating profit excludes other income and (expense), net; income and expense not associated with the business segments; and the costs of corporate decisions related to the strategic cost reductions described in Note 3.

The principal sources of revenue in each global business segment are described below.

The Personal Care segment manufactures and markets disposable diapers, training and youth pants and swimpants; baby wipes; feminine and incontinence care products; and related products. Products in this segment are primarily for household use and are sold under a variety of brand names, including Huggies, Pull-Ups, Little Swimmers, GoodNites, Kotex, Lightdays, Depend, Poise and other brand names.

·	The Consumer Tissue segment manufactures and markets facial and bathroom tissue, paper towels, napkins and related products for household use. Products in this segment are sold under the Kleenex, Scott, Cottonelle, Viva, Andrex, Scottex, Hakle, Page and other brand names.

The K-C Professional & Other segment manufactures and markets facial and bathroom tissue, paper towels, napkins, wipers and a range of safety products for the away-from-home marketplace. Products in this segment are sold under the Kimberly-Clark, Kleenex, Scott, WypAll, Kimtech, KleenGuard and Kimcare brand names.

The Health Care segment manufactures and markets disposable health care products such as surgical gowns, drapes, infection control products, sterilization wrap, face masks, exam gloves, respiratory products and other disposable medical products. Products in this segment are sold under the Kimberly-Clark, Ballard and other brand names.

Note 9. (Continued)

The following schedules present information concerning consolidated operations by business segment:

	Three Months
	Ended March 31
(Millions of dollars)	2009			2008

NET SALES:

Personal Care	$	1,977		$	2,046
Consumer Tissue		1,574			1,707
K-C Professional & Other		651			761
Health Care		298			298
Corporate & Other		13			22
Intersegment sales		(20	)		(21	)

Consolidated	$	4,493		$	4,813

	Three Months
	Ended March 31
(Millions of dollars)	2009			2008

OPERATING PROFIT (reconciled to income before income taxes):

Personal Care	$	442		$	428
Consumer Tissue		194			156
K-C Professional & Other		80			97
Health Care		48			46
Other income and (expense), net(a)(b)		(77	)		7
Corporate & Other(b)		(59	)		(70	)

Consolidated Operating Profit		628			664

Interest income		8			8
Interest expense		(73	)		(74	)

Income Before Income Taxes	$	563		$	598

Notes:

(a) 2009 includes $76 million of currency transaction losses versus $12 million of currency transaction gains in 2008.

(b) For the period ended March 31, 2008, Other income and (expense), net includes $(1) million and Corporate & Other includes $(23) million of

pretax amounts for the strategic cost reductions.

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

Introduction

This management’s discussion and analysis of financial condition and results of operations is intended to provide investors with an understanding of the Corporation’s recent performance, its financial condition and its prospects. The following will be discussed and analyzed:

·	Overview of First Quarter 2009 Results

·	Results of Operations and Related Information

·	Liquidity and Capital Resources

·	New Accounting Standards

·	Environmental Matters

·	Business Outlook

Overview of First Quarter 2009 Results

·	Net sales decreased 6.6 percent.

·	Operating profit and net income attributable to Kimberly-Clark Corporation decreased 5.4 percent and 7.7 percent, respectively.

·	Cash provided by operations was $692 million, an increase of 55.9 percent over last year.

Results of Operations and Related Information

This section presents a discussion and analysis of the Corporation’s first quarter of 2009 net sales, operating profit and other information relevant to an understanding of the results of operations.

First Quarter of 2009 Compared With First Quarter of 2008

Analysis of Net Sales

By Business Segment

(Millions of dollars)

Net Sales	2009			2008

Personal Care	$	1,977		$	2,046
Consumer Tissue		1,574			1,707
K-C Professional & Other		651			761
Health Care		298			298
Corporate & Other		13			22
Intersegment sales		(20	)		(21	)

Consolidated	$	4,493		$	4,813

Commentary:

	Percent Change in Net Sales Versus Prior Year
			Changes Due To
	Total		Volume		Net			Mix/
	Change		Growth		Price	Currency		Other

Consolidated	(6.6	)	(3	)	6	(10	)	-

Personal Care	(3.4	)	1		6	(11	)	1
Consumer Tissue	(7.8	)	(5	)	6	(10	)	1
K-C Professional & Other	(14.5	)	(9	)	5	(9	)	(1	)
Health Care	-		4		-	(4	)	-

Personal care net sales in North America increased about 2 percent versus the year-ago quarter, as improvements in net selling prices and product mix of 5 percent and 1 percent, respectively, were partially offset by decreases in sales volumes and unfavorable currency effects of 2 percent each. The higher net selling prices resulted from increases implemented during 2008 across all categories, net of increased competitive promotional activity, mainly for Huggies diapers. Although product innovations contributed to solid volume gains for Depend and Poise adult care products, sales volumes for the Corporation’s child care and baby wipes brands were down high single digits, due in part to a slowdown in category sales. Meanwhile, first quarter sales volumes of Huggies diapers and Kotex feminine care products declined slightly.

In Europe, personal care net sales fell approximately 22 percent in the quarter. Unfavorable currency exchange rates accounted for almost 19 percentage points of the decrease. Sales volumes were down about 3 percent compared with the prior year primarily as a result of lower sales of child care products, and net selling prices were down less than 1 percent. Although sales volumes for Huggies diapers were little changed across the region, they were up in the growing Central European markets, but down in the Corporation’s four core markets of the U.K., France, Italy and Spain.

In developing and emerging markets, personal care net sales decreased about 5 percent, as continued growth in organic sales was more than offset by negative currency effects of 20 percent. Sales volumes increased approximately 5 percent, while net selling prices improved nearly 9 percent and product mix was better by approximately 1 percent. The growth in organic sales was broad-based, with particular strength in China, South Korea, Russia, Turkey, South Africa, Vietnam, Brazil and the Andean region in Latin America.

In North America, net sales of consumer tissue products increased about 1 percent in the first quarter, as an increase in net selling prices of more than 5 percent and improved product mix of about 2 percent were mostly offset by a 5 percent decline in sales volumes and negative currency effects of 1 percent. The improvement in net selling prices reflects list price increases implemented across the bathroom tissue, paper towel and facial tissue categories during 2008, partially offset by an increase in competitive promotional activity. The lower sales volumes reflect the Corporation’s focus on improving revenue realization, as well as slower category growth and consumer trade-down. For the quarter, volume levels were down high-single digits across the Viva and Scott paper towel brands and mid-single digits for Kleenex facial tissue. Overall bathroom tissue sales volumes were down low-single digits, as higher Scott Tissue volumes were more than offset by lower Cottonelle volumes.

In Europe, consumer tissue net sales dropped nearly 21 percent compared with the first quarter of 2008 on weaker foreign currency exchange rates of approximately 18 percent. Sales volumes were down more than 6 percent, due mainly to lower sales of Andrex and Scottex bathroom tissue in response to higher prices and continued softness in category sales, particularly in the U.K. Net selling prices improved 3 percent, primarily for bathroom tissue in most markets across the region, and product mix also was better by 1 percent.

Consumer tissue net sales in developing and emerging markets were lower by more than 11 percent, driven by unfavorable currency effects of approximately 19 percent and a 4 percent decline in sales volumes. These factors more than offset a double-digit increase in net selling prices, as the Corporation raised prices in most markets over the past year to recover higher raw materials costs.

Net sales of K-C Professional (“KCP”) & other products decreased 14.5 percent compared with the first quarter of 2008. Overall sales volumes fell more than 9 percent; changes in foreign currency rates also reduced sales by 9 percent and product mix was unfavorable by about 1 percent, partially offset by a 5 percent improvement in net selling prices. Economic weakness and rising unemployment levels in North America and Europe had a significant effect on KCP’s categories in the first quarter. In North America, net sales declined approximately 10 percent. While net selling prices rose by 5 percent, sales volumes declined nearly 13 percent, and product mix and currency effects both were negative by about 1 percent. In Europe, KCP’s sales went down 24 percent in the first quarter, as sales volumes were almost 10 percent lower, product mix was off 1 percent and weaker currencies depressed sales by about 17 percent. These factors were partially offset by a 4 percent benefit from price increases implemented during 2008. Across developing and emerging markets, net sales were down about 12 percent, primarily reflecting adverse currency effects of almost 19 percent, while sales volumes and net selling prices were higher by approximately 2 percent and 6 percent, respectively.

Net sales of health care products were unchanged in the first quarter, as growth in sales volumes of 4 percent was offset by unfavorable currency exchange rates. The improvement in sales volumes was driven by mid-single digit growth in North America, with particular strength in sales of exam gloves, and double-digit growth in developing and emerging markets. Sales volumes in Europe, however, were down mid-single digits.

By Geography

(Millions of dollars)

Net Sales	2009			2008

North America	$	2,539		$	2,551
Outside North America		2,105			2,432
Intergeographic sales		(151	)		(170	)

Consolidated